David Silberstein

BMO Bank NA (Investment Management) (BMO-IM) is the asset management division of BMO Bank NA, headquartered in Chicago, Illinois. They are ultimately held by the Bank of Montreal (TSE: BMO) in Canada. BMO-IM offers a variety of wealth management services, such as investment advisory, trust, banking, and financial planning, to institutions and high-net worth clients.

HBK Investments LP, do-business-as HBK Capital Management (HBK), is a SEC-registered investment advisor and hedge fund manager headquartered in Dallas, Texas. The firm was founded in 1991 and is a subsidiary of HBK Partners II LP. HBK provides discretionary investment management services and related administrative services to their funds, which are private investment funds offered only to sophisticated investors with substantial resources.

EpicEdge, Inc. is an information technology consulting firm which focuses on serving state and local government agencies and technology & commercial customers. The firm helps its clients to meet their business goals through implementation and support of client/server & Internet-enabled enterprise software packages, custom Web application development and strategic consulting. It delivers successful IT project-based services by combining the elements of market-leading and third-party products such as PeopleSoft. The company was founded on June 5, 1979 and is headquartered in Austin, TX.

VC Units Co. LLC provided investment advice. The company was founded in 1984 and was headquartered in Chicago, IL.

BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX.

Mill Creek Life Sciences LLC engages in the provision of tools and technologies for therapy. It focuses on the development and application of cellular and biologic therapeutics. Its products include PLTGold and PLTMax. The company was founded by Steven L. Dietz and Judy Lundy on May 27, 2010 and is headquartered in Rochester, MN.

Perritt Capital Management, Inc. (PCM) is a registered investment advisor headquartered in Chicago, Illinois. The firm was founded by Gerald W. Perritt in 1987 and is a wholly owned subsidiary of Investment Information Services, Inc. PCM provides discretionary and non-discretionary investment advisory services to individuals, institutions, trusts, and other entities that require investment advice on an ongoing basis. They also serve as an investment adviser to The Perritt Funds, Inc., which has two series: the MicroCap Opportunities Fund, and the Ultra MicroCap Fund.

Part of Woodbridge Co. Ltd. /New/, On Line Capital Advisors LLC is an investment advisory firm. On Line Capital Advisors was acquired by CDA Investment Technologies from Titan Financial Group LLC on July 22, 1996.

National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.

Texas Healthcare & Bioscience Institute is a membership association that serves as a public policy voice for the healthcare and bioscience industry. The non-profit company is based in Austin, TX.

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

Cowtown Angels operates as a financial investment group that supports startups and early stage businesses. The company was founded by Darlene Boudreaux and is headquartered in Fort Worth, TX.

Part of BIOS Capital Management LP, Steelhead Capital Management LLC is an alternative investment manager. The company is based in Fort Worth, TX and was founded in 2008.

BIOS Capital Management LP (BIOS Partners) is a venture capital firm founded in 2014 by Stella Robertson, Aaron Fletcher and Leslie Kreis. The firm is headquartered in Fort Worth, Texas.

Part of BIOS Capital Management LP, BIOS Equity Partners LP functions as a private equity firm. The company is based in Texas. The American company was founded by Leslie W. Kreis.

Part of BIOS Capital Management LP, BIOS Equity Partners II LP provides investment services. The company is based in Fort Worth, TX. The company was founded by Leslie W. Kreis.

Mayo Clinic Cancer Center operates a cancer center. The private company is based in Phoenix.

Keystone Bio, Inc. engages in operation PharmaBiome biotech company. It develops pathogen of chronic inflammation that is shown to initiate and advance Atherosclerosis, heart disease, and Alzheimer's disease. The company is headquartered in St. Louis, MO.

Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN.

MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University.

iGan Partners (iGan Partners) is a venture capital firm founded in 2010 by Sam Ifergan. The firm is headquartered in Toronto, Canada.

SIRPant Immunotherapeutics, Inc. is a clinical-stage immuno-oncology company based in Hummelstown, PA. The company specializes in developing next-generation macrophage-based immunotherapies for the treatment of hematological malignancies and solid tumors. The cell therapy technology employed by SIRPant is based on the reduction of SIRP? expression combined with activation of the patient's own macrophages. This population of SIRP?low activated macrophages is designed to attack the tumor following injection by activating the patient's immune system to produce broad-spectrum anti-tumor activity that utilizes patient T-cells and antibodies targeting cancer neoantigens. The company was founded by Richard F. Fitzgerald, and the CEO is Robert J. Towarnicki.